159 related articles for article (PubMed ID: 34123851)
1. Differences in Prostate Cancer Incidence and Mortality in Lower Saxony (Germany) and Groningen Province (Netherlands): Potential Impact of Prostate-Specific Antigen Testing.
Kappen S; de Bock GH; Sirri E; Vohmann C; Kieschke J; Winter A
Front Oncol; 2021; 11():681006. PubMed ID: 34123851
[TBL] [Abstract][Full Text] [Related]
2. Penile cancer - Incidence, mortality, and survival in Saxony, Germany.
Schoffer O; Neumann A; Stabenow R; Schülein S; Böhm WD; Gonsior A; Horn LC; Kriegel C; Stolzenburg JU; Wirth M; Klug SJ
Urol Oncol; 2019 Apr; 37(4):295.e1-295.e8. PubMed ID: 30595462
[TBL] [Abstract][Full Text] [Related]
3. Attitudes Toward and Use of Prostate-Specific Antigen Testing Among Urologists and General Practitioners in Germany: A Survey.
Kappen S; Jürgens V; Freitag MH; Winter A
Front Oncol; 2021; 11():691197. PubMed ID: 34150662
[TBL] [Abstract][Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
5. Past, Current, and Future Incidence Rates and Burden of Metastatic Prostate Cancer in the United States.
Kelly SP; Anderson WF; Rosenberg PS; Cook MB
Eur Urol Focus; 2018 Jan; 4(1):121-127. PubMed ID: 29162421
[TBL] [Abstract][Full Text] [Related]
6. Periodic trends in geographical variation of prostate cancer incidence and mortality in Finland between 1985 and 2019.
Seikkula H; Kaipia A; Boström PJ; Malila N; Pitkäniemi J; Seppä K
Acta Oncol; 2022 Oct; 61(10):1209-1215. PubMed ID: 36008888
[TBL] [Abstract][Full Text] [Related]
7. Comparison of prostate cancer survival in Germany and the USA: can differences be attributed to differences in stage distributions?
Winter A; Sirri E; Jansen L; Wawroschek F; Kieschke J; Castro FA; Krilaviciute A; Holleczek B; Emrich K; Waldmann A; Brenner H;
BJU Int; 2017 Apr; 119(4):550-559. PubMed ID: 27208546
[TBL] [Abstract][Full Text] [Related]
8. Early detection of prostate cancer using prostate-specific antigen testing: an empirical evaluation among general practitioners and urologists.
Kappen S; Jürgens V; Freitag MH; Winter A
Cancer Manag Res; 2019; 11():3079-3097. PubMed ID: 31114352
[No Abstract] [Full Text] [Related]
9. The national-wide incidence of prostate-specific antigen testing trend for a decade in Korea by age group.
Ko YH; Roh KC; Kim BH
Investig Clin Urol; 2022 Mar; 63(2):184-191. PubMed ID: 35244992
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer mortality in screen and clinically detected prostate cancer: estimating the screening benefit.
van Leeuwen PJ; Connolly D; Gavin A; Roobol MJ; Black A; Bangma CH; Schröder FH
Eur J Cancer; 2010 Jan; 46(2):377-83. PubMed ID: 19804966
[TBL] [Abstract][Full Text] [Related]
11. Incidence of prostate cancer in Eritrea: Data from the National Health Laboratory, Orotta Referral Hospital and Sembel Hospital 2011-2018.
Medhin LB; Achila OO; Syum BE; Gebremichael KH; Said SM; Lobeck H; Ghidei YT
PLoS One; 2020; 15(4):e0232091. PubMed ID: 32324838
[TBL] [Abstract][Full Text] [Related]
12. Prostate Cancer Incidence and Mortality Following a Negative Biopsy in a Population Undergoing PSA Screening.
Pierre-Victor D; Parnes HL; Andriole GL; Pinsky PF
Urology; 2021 Sep; 155():62-69. PubMed ID: 34186135
[TBL] [Abstract][Full Text] [Related]
13. The impact of socioeconomic status on stage specific prostate cancer survival and mortality before and after introduction of PSA test in Finland.
Seikkula HA; Kaipia AJ; Ryynänen H; Seppä K; Pitkäniemi JM; Malila NK; Boström PJ
Int J Cancer; 2018 Mar; 142(5):891-898. PubMed ID: 29044563
[TBL] [Abstract][Full Text] [Related]
14. Time trends of major cancers incidence and mortality in Guangzhou, China 2004-2015: A Joinpoint and Age-Period-Cohort Analysis.
Luo A; Dong H; Lin X; Liao Y; Liang B; Chen L; Lin G; Hao Y
Cancer Med; 2021 Apr; 10(8):2865-2876. PubMed ID: 33724715
[TBL] [Abstract][Full Text] [Related]
15. Trends in incidence and mortality rates for prostate cancer before and after prostate-specific antigen introduction. A registry-based study in southeastern Netherlands, 1971-1995.
Post PN; Kil PJ; Crommelin MA; Schapers RF; Coebergh JW
Eur J Cancer; 1998 Apr; 34(5):705-9. PubMed ID: 9713278
[TBL] [Abstract][Full Text] [Related]
16. Contamination in control group led to no effect of PSA-based screening on prostate cancer mortality at 9 years follow-up: Results of the French section of European Randomized Study of Screening for Prostate Cancer (ERSPC).
Villers A; Bessaoud F; Trétarre B; Grosclaude P; Malavaud B; Rebillard X; Iborra F; Daubisse L; Malavaud S; Roobol M; Heijnsdijk EA; de Koning HJ; Hugosson J; Rischmann P; Soulié M
Prog Urol; 2020 Apr; 30(5):252-260. PubMed ID: 32197936
[TBL] [Abstract][Full Text] [Related]
17. A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer.
Hugosson J; Roobol MJ; Månsson M; Tammela TLJ; Zappa M; Nelen V; Kwiatkowski M; Lujan M; Carlsson SV; Talala KM; Lilja H; Denis LJ; Recker F; Paez A; Puliti D; Villers A; Rebillard X; Kilpeläinen TP; Stenman UH; Godtman RA; Stinesen Kollberg K; Moss SM; Kujala P; Taari K; Huber A; van der Kwast T; Heijnsdijk EA; Bangma C; De Koning HJ; Schröder FH; Auvinen A;
Eur Urol; 2019 Jul; 76(1):43-51. PubMed ID: 30824296
[TBL] [Abstract][Full Text] [Related]
18. Impact of Metabolic Diseases, Drugs, and Dietary Factors on Prostate Cancer Risk, Recurrence, and Survival: A Systematic Review by the European Association of Urology Section of Oncological Urology.
Campi R; Brookman-May SD; Subiela Henríquez JD; Akdoğan B; Brausi M; Klatte T; Langenhuijsen JF; Linares-Espinos E; Marszalek M; Roupret M; Stief CG; Volpe A; Minervini A; Rodriguez-Faba O
Eur Urol Focus; 2019 Nov; 5(6):1029-1057. PubMed ID: 29661588
[TBL] [Abstract][Full Text] [Related]
19. Global Incidence and Mortality for Prostate Cancer: Analysis of Temporal Patterns and Trends in 36 Countries.
Wong MC; Goggins WB; Wang HH; Fung FD; Leung C; Wong SY; Ng CF; Sung JJ
Eur Urol; 2016 Nov; 70(5):862-874. PubMed ID: 27289567
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
